Home
Home
  • Home
  • About Us About Us
    • Overview
    • Who we are
    • Why we provide advice
    • What are health technologies
    • Meetings
    • News
    • Who we work with
    • Contact Us
  • What We Do What We Do
    • Overview
    • Our Strategy
    • Work programme
    • Range of advice products
    • Quarterly Bulletin of advice
    • Early HTA Advice Service
  • Our Advice
  • Request Advice Request Advice
    • Overview
    • Form for requesting advice
  • Get Involved Get Involved
    • Overview
    • Contribute to advice
    • NHS boards
    • Patient and Public Involvement
    • Industry Involvement
    • Observe a council meeting
    • DOI Form

Advice Statement

  • Home
  • Our Advice
  • Robot-assisted surgery compared with laparoscopic resection for the treatment of rectal cancer

Title

Output Type

Speciality

Published

Title

Robot-assisted surgery compared with laparoscopic resection for the treatment of rectal cancer

Output Type

Advice Statement

Speciality

Cancer, Digestive System, Genitourinary system

Published

2 November 2018

Recommendation for NHSScotland

Robot-assisted surgery should be considered for patients with rectal cancer who have a narrow pelvis, are obese (BMI≥30), and/or have a tumour located in the mid-to-low rectum. There is evidence of a clinical benefit in the form of reduced risk of conversion to open surgery in these patients, although relevant cost-effectiveness evidence is currently lacking. Expert opinion indicates that conventional laparoscopic options are inadequate for these patients.

Data on clinical, oncological and patient-important outcomes should be collected for all robot-assisted surgeries in patients with rectal cancer who meet the criteria outlined above.

Provision of robot-assisted surgery for rectal cancer should be concentrated within centres that currently have a robotic surgical device and are likely to be receive a sufficient number of suitable patients per year to maintain surgeon proficiency.

NHSScotland is required to consider the Scottish Health Technologies Group (SHTG) advice.

What were we asked to look at?

We were asked to provide advice on the use of robot-assisted surgery for the treatment of rectal cancer, based on the published evidence and a patient organisation submission.  

Why is this important?

Da Vinci® robotic surgical devices are a relatively new technology which is available at four centres in NHSScotland. These devices are currently used predominantly to provide a laparoscopic prostatectomy service. To ensure the devices are optimally employed, NHSScotland is considering expanding the indications for which robot-assisted surgery is available.

Referred by 

NHS Greater Glasgow and Clyde 

 

Download icon
Download Advice
pdf (416 KB)
Download icon
Download Plain Language Summary
pdf (191 KB)
Download icon
Download Evidence Note
pdf (450 KB)
Download icon
Download Patient Submission
pdf (91 KB)

Connect with Us

Please let us know if you'd like to receive regular updates on our work.


Last Updated: 31 January 2022

Scottish Health Technologies Group

© 2021, All rights reserved

  • Accessibility
  • Respecting your privacy
  • Cookies
  • Healthcare Improvement Scotland Website
  • Find us on Twitter
  • Freedom of Information

Tell us what you think


We'd love to hear your views

Was our advice useful?  Did you find what you were looking for on our website?